Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome

Neuroendocrinology

Volumn 94, Issue 1, 2011, Pages 58-65

  Davì, Maria Vittoria ^a   Boninsegna, Letizia ^a   Dalle Carbonare, Luca ^a   Toaiari, Marco ^a   Capelli, Paola ^a   Scarpa, Aldo ^a   Francia, Giuseppe ^a   Falconi, Massimo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Multiple endocrine neoplasia type 1; Pancreaticoduodenal endocrine tumors; Primary hyperparathyroidism

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; ENDOCRINE TUMOR; FEMALE; HUMAN; HYPERPARATHYROIDISM; INSULINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

ADOLESCENT; ADULT; CHILD; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULINOMA; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT; ZOLLINGER-ELLISON SYNDROME;

EID: 79960933720     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000326164     Document Type: Article

References (33)

1. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA: Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann Intern Med 1998; 15: 484-494. (Pubitemid 28428085)
2. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658-5671. (Pubitemid 33152604)
3. Jensen RT, Berna MJ, Bingham DB, Norton J: Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 2008; 1: 1807-1843.
4. Benson L, Ljunghall S, Akerström G, Oberg K: Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 1987; 82: 731-737.
5. Thakker RV: Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 2000; 29: 541-567.
6. Gibril F, Shumann M, Pace A, Jensen RT: Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: A prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 2004; 83: 43-83. (Pubitemid 38124855)
7. Skogseid B, Eriksson B, Lundqvist G, Lörelius LE, Rastad J, Wide L, Akerström G, Oberg K: Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991; 73: 281-287. (Pubitemid 21921870)
8. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, Jensen RT: Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I. Am J Med 1994;97: 436-444. (Pubitemid 24345595)
9. Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A, Proye CA: Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 2006; 243: 265-272. (Pubitemid 43185447)
10. Mignon M, Cadiot G: Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med 1998; 243: 489-494. (Pubitemid 28312245)
11. Norton JA, Jensen RT: Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 2004; 240: 757-773. (Pubitemid 39425767)
12. Falconi M, Plockinger U, Kwekkeboom DJ, Manfredi R, Korner M, Kvols L, Pape UF, Ricke J, Goretzki PE, Wildi S, Steinmuller T, Oberg K, Scoazec JY; Frascati Consensus Conference; European Neuroendocrine Tumor Society: Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 2006; 84: 196-211. (Pubitemid 46361054)
13. Klöppel G, Perren A, Heitz PU: The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification. Ann NY Acad Sci 2004; 1014: 13-27. (Pubitemid 38594787)
14. Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, du Boullay Choplin H, Chabre O, Jovenin N, Cadiot G; Groupe des Tumeurs Endocrines (GTE): Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 2006; 101: 266-273. (Pubitemid 43381666)
15. Wamsteker EJ, Gauger PG, Thompson NW, Scheiman JM: EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia. Gastrointest Endosc 2003; 58: 531-535. (Pubitemid 37205765)
16. Kann PH, Balakina E, Ivan D, Bartsch DK, Meyer S, Klose K-J, Behr Th, Langer P: Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: An endoscopic ultrasound imaging study. Endocr Relat Cancer 2006; 13: 1195-1202. (Pubitemid 46212573)
17. Vasen HF, Lamers CB, Lips CJ: Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands. Arch Intern Med 1989; 149: 2717-2722. (Pubitemid 20009729)
18. Cadiot G, Houillier P, Allouch A, Paillard M, Mignon M: Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison. Gut 1996; 39: 273-278. (Pubitemid 26276006)
19. Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D'Agruma L, Minisola S, Corbetta S, Cole DE, Spada A, Scillitani A: Sporadic and MEN1-related primary hyperparathyroidism: Differences in clinical expression and severity. J Bone Miner Res 2009; 24: 1404-1410.
20. Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS: Hyperparathyroidism in hereditary syndromes: Special expressions and special managements. J Bone Miner Res 2002; 17: 37-43.
21. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV: Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 1996; 89: 653-669. (Pubitemid 26319017)
22. Lévy-Bohbot N, Merle C, Goudet P, Delemer B, Calender A, Jolly D, Thiéfin G, Cadiot G; Groupe des Tumeurs Endocrines: Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: Study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol Clin Biol 2004; 28: 1075-1081. (Pubitemid 39655853)
23. O'Riordain DS, O'Brien T, van Heerden JA, Service FJ, Grant CS: Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg 1994; 18: 488-493, discussion 493-494.
24. Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH: Insulinomas associated with multiple endocrine neoplasia type I: The need for a different surgical approach. Surgery 1991; 110: 998-1004, discussion 1004-1005.
25. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999; 26: 635-644. (Pubitemid 29399042)
26. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT: Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 2001; 234: 495-505.
27. Tonelli F, Fratini G, Nesi G, Tommasi MS, Batignani G, Falchetti A, Brandi ML: Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg 2006; 244: 61-70. (Pubitemid 44297449)
28. Bartsch DK, Fendrich V, Langer P, Celik I, Kann PH, Rothmund M: Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 2005; 242: 757-764, discussion 764-766.
29. Cadiot G, Vuagnat A, Doukhan I, Murat A, Bonnaud G, Delemer B, Thiéfin G, Beckers A, Veyrac M, Proye C, Ruszniewski P, Mignon M: Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 1999; 116: 286-293.
30. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT: Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994; 220: 320-330. (Pubitemid 24313225)
31. de Herder WW, Krenning EP, Van Eijck CH, Lamberts SW: Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumors of the gastrointestinal tract and pancreas. Endocr Relat Cancer 2004; 11: 19-34. (Pubitemid 38419721)
32. Cougard P, Goudet P, Peix JL, Henry JF, Sarfati E, Proye C, Calender A: Insulinomas in multiple endocrine neoplasia type 1. Report of a series of 44 cases by the multiple endocrine neoplasia study group (in French). Ann Chir 2000; 125: 118-123. (Pubitemid 30219760)
33. Thompson NW: Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 1998; 243: 495-500. (Pubitemid 28312246)